Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.
Rodak M, Dekempeneer Y, Wojewódzka M, Caveliers V, Covens P, Miller BW, Sevenois MB, Bruchertseifer F, Morgenstern A, Lahoutte T, D'Huyvetter M, Pruszyński M.
Rodak M, et al. Among authors: morgenstern a.
Mol Cancer Ther. 2022 Dec 2;21(12):1835-1845. doi: 10.1158/1535-7163.MCT-21-1021.
Mol Cancer Ther. 2022.
PMID: 36129807
Free PMC article.